Daniela Fioretti earned a Ph.D. in Immunology in 1999 and has been a molecular biology and in vivo model researcher at the Institute of Translational Pharmacology (IFT-CNR) since 2005. She obtained a research fellowship for a collaborative research project on the engraftment competence and regenerative in vivo potential of bi-potent hepatic precursors at the INSERM Unité 542, Hôpital Paul Brousse, Villejiuf, Université Paris XI, France. She was a participant in the European project “REGENERATION”, Horizon Marie Skłodowska-Curie Actions (HORIZON-MSCA-2022-SE-01) and the project “A Graphene-Based 3D-Printable Scaffold with Photothermal Effect for Tumor Therapy and Bone Regeneration”, Progetto AIRC (Area: Targeted therapy and new therapeutics), Ref. IG 2019-ID.23124. She was a Scientific Collaborator for the project Ecosistema dell’Innovazione “Rome Technopole” ECS00000024, PNRR financed by the European Union – NextGeneration EU Spoke n. 5 – Out-reach. Over the last ten years, her scientific interest has been focused on the study and analysis of biocompatibility of biomaterials intended for therapeutic protocols in tissue damage models and cancer therapy, study of in vivo model for tissue damage, and study of genetic vaccinations against cancer. She is an author of about 40 peer-reviewed scientific papers. H-index: 17.